EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Transcutaneous electrical nerve stimulation in the management of restless legs syndrome symptoms: A single‐blind, parallel‐group clinical study

Zeynep Selcan Şanli iD, Emine Aygül Ortaç, Hülya Binokay iD, Kübra Aktaş

Journal of Sleep Research · 2024-10 · 33 (5)

DOI: 10.1111/jsr.14167 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Sleep Research, online erschienen am 15.02.2024. Verfasst von Zeynep Selcan Şanli und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Adana City Training and Research Hospital, University of Health Sciences, Adana, Turkey. Hauptthemen laut MEDLINE: Restless Legs Syndrome, Transcutaneous Electric Nerve Stimulation, Pramipexole. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aim of this study was to investigate the additional effect of transcutaneous electrical nerve stimulation (TENS) on the control of the symptoms of restless legs syndrome (RLS). A total of 46 randomly selected patients diagnosed with RLS were divided into two groups in a single‐blind study to either receive pramipexole (0.25 mg daily) plus 10 sessions of TENS or only pramipexole (0.25 mg daily) for 4 weeks. The severity of the symptoms was determined according to the International Restless Legs Syndrome Rating Scale (IRLSRS) and the Pittsburgh sleep quality index (PSQI) at the beginning of the treatment, post‐treatment, and at an 8 week follow‐up. A significant time interaction was observed between the groups for all measurement outcomes, revealing differences in favour of the experimental group's IRLSRS and PSQI scores. A notable improvement was also observed in the IRLSRS and PSQI scores in both groups at the end of treatment and during the 8 week follow‐up period. In comparison with pramipexole monotherapy, the results of this study showed that the use of TENS therapy combined with a low dose of pramipexole (0.25 mg daily) is therapeutically beneficial in the treatment of RLS over an 8 week follow‐up period.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Restless Legs SyndromeTranscutaneous Electric Nerve StimulationPramipexoleHumansSingle-Blind MethodFemaleMaleMiddle AgedTreatment OutcomeBenzothiazolesDopamine AgonistsAdultSeverity of Illness IndexAgedCombined Modality Therapy

Stichwörter der Autor:innen

neuromodulationrestless legs syndromesleep qualitytranscutaneous electrical nerve stimulation

Substanzen

PramipexoleBenzothiazolesDopamine Agonists

Autor:innen und Institutionen

  • Department of Neurology, Adana City Training and Research Hospital, University of Health Sciences, Adana, Turkey.
  • Department of Physical Medicine and Rehabilitation, Adana City Training and Research Hospital, University of Health Sciences, Adana, Turkey.
  • Department of Biostatistics and Medical Informatics, Cukurova University, Adana, Turkey.

ORCID-Profile: Zeynep Selcan Şanli, Hülya Binokay

Zitieren

APA

Şanli, Z. S., Ortaç, E. A., Binokay, H., & Aktaş, K. (2024). Transcutaneous electrical nerve stimulation in the management of restless legs syndrome symptoms: A single‐blind, parallel‐group clinical study. Journal of Sleep Research, 33(5). https://doi.org/10.1111/jsr.14167

Vancouver

Şanli ZS, Ortaç EA, Binokay H, Aktaş K. Transcutaneous electrical nerve stimulation in the management of restless legs syndrome symptoms: A single‐blind, parallel‐group clinical study. Journal of Sleep Research. 2024;33(5). doi:10.1111/jsr.14167

BibTeX
@article{anli2024,
  author = {Şanli, Zeynep Selcan and Ortaç, Emine Aygül and Binokay, Hülya and Aktaş, Kübra},
  title = {Transcutaneous electrical nerve stimulation in the management of restless legs syndrome symptoms: A single‐blind, parallel‐group clinical study},
  journal = {Journal of Sleep Research},
  year = {2024},
  volume = {33},
  number = {5},
  doi = {10.1111/jsr.14167}
}
Kostenlos starten →